Sunday

ThursdayFridaySaturdaySundayMonday

Sunday

  Clinical Track Interdisciplinary Track Interdisciplinary Track Ayahuasca Track
  East Hall Jr. Ballroom Room 208 Grand Ballroom
7:00 Registration Opens
7:30 Complimentary Continental Breakfast in the West Hall
9:00 Michael Bogenschutz, MD: Psilocybin-Assisted Treatment for Alcohol Dependence Brad Burge, Arianne Cohen, Lakshmi Narayan: Repositioning Psychedelics in the Public Mind Tomáš Páleníček: Behavioral, Neurochemical, and Pharmaco-EEG Profiles of 2C-B in Rats Sidarta Ribeiro, PhD: How Similar to Dreaming is the Ayahuasca Experience?
9:30 Steve Ross, MD: Psilocybin, Addiction, and End of Life
9:45 Sue Sisley, MD: Marijuana for PTSD: Existing Evidence and MAPS’ FDA-Approved Protocol Diana Slattery: Communicating the Unspeakable: Linguistic Phenomena in the Psychedelic Sphere
10:00 Eduardo Gastelumendi, MD: A Psychoanalytic Perspective on Ayahuasca: Insight, Transitional Space, and Potential Side Effects
10:30 Break
11:00 Roland Griffiths, PhD: Johns Hopkins Psilocybin Research Project: Studies of Mystical Experience and Meditation in Healthy Volunteers, and Palliative Effects in Cancer Patients Thomas Kingsley Brown, PhD: Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico Ilsa Jerome, PhD: Learning from Listening: Qualitative Data in MDMA-Assisted Therapy Research Clancy Cavnar, PsyD: The Effects of Participation in Ayahuasca Rituals on Gay’s and Lesbian’s Self Perception
11:30 Geoff Noller MD: Notes on Progress in the New Zealand Ibogaine Study Jan Weinhold, PhD: Santo Daime in Europe: Ritual Transfer and Cultural Translations
12:00 Phil Wolfson, MD: The Varieties of Ketamine Experience Amir Raz, MD: The Neural Correlates of Altered Consciousness: From Hypnosis and Meditation to Drug-Based Changes Marc Blainey PhD(c): Ayahuasca Therapy and Santo Daime Mysticism in Europe: Ethnographic Challenges to Prohibition
12:30 Lunch
2:00 Charles Grob, MD: Psilocybin at the End of Life Earth and Fire Erowid: State of the Stone 2013: Drugs of the Future, Now Leonardo Rodriguez-Perez: Gaultheria Insipida: A Female Psychedelic Plant from the Andes Jeffrey Bronfman:  Federal Government Licensing of Ayahuasca Use and Personal and Religious Freedom
2:30 Amanda Feilding: The Beckley Foundation’s Program of Psychedelic Research Frank Echenhofer, PhD, Tara Samiy PsyD & Matt Spalding, PsyD: Systematic Methods of Exploring Psychedelic Experiences Doug Robinson: Why People Climb Mountains Kevin Feeney, JD and Beatriz Caiuby Labate, PhD: The Expansion of Brazilian Ayahuasca Religions: Law, Culture, and Locality
3:00 Matt Johnson, PhD: Psilocybin-Facilitated Treatment for Addiction: Smoking Cessation Genesee Herzberg, PsyD:  The Phenomenology and Sequelae of MDMA-Assisted Therapy: A Pilot Study Kenneth Tupper, PhD: The Economics of Ayahuasca
3:30 Break (cash & carry)
4:00 Robin Carhart-Harris, PhD: Brain Imaging Studies with Psilocybin and MDMA Matthew Baggott, PhD: Quantitative Analysis of Narrative Reports of Psychedelic Drugs Austin Shaw: Creativity, Cosmology, and Communion: A Buddhist View on the Sacred Significance of Psychedelics Jessica L. Nielson, PhD and Julie D. Megler, MSN, NP-BC: Ayahuasca for PTSD: Integrating Psychedelic Therapeutic Strategies for Neurotrauma into a Bioinformatics Framework
4:30 Jeffrey Guss MD: The NYU Training Program for Psychedelic Psychotherapy David Nickles: In Search of Entheogenic Molecules: Phytochemical Analysis from the DMT-Nexus José Carlos Bouso: Long-Term Effects of the Ritual Use of Ayahuasca on Mental Health
5:00 David Nutt, P
hD:  The Beckley-Imperial Psychedelic Research Program
Sean Leneghan: A Phenomenologically Grounded Ethnographic Study of the Life-World of Ecstasy Users Alex Gearin, PhD (C): A Comparative Analysis of Ayahuasca Healing in Amazonia and Australia
5:30 Closing Remarks: Rick Doblin, PhD, Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS)
Amanda Feilding, Founder and Director, The Beckley Foundation
Bob Jesse, Convener, Council on Spiritual Practices (CSP)
David Nichols, PhD, Co-Founder and Director of Preclinical Research, Heffter Research Institute
6:00 Conference End
6:30 Stan Grof Lecture

Sunday Film
12:30 PM • Breaking the Taboo • Room OCC 208